Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Fetal bovine serum (FBS) has long served as a foundational input for cell culture, tissue engineering, and biomanufacturing.

A chance encounter on a rocky seashore led one professor to invent autonomous robotics that can harvest the power of seaweed.

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our decentralized manufacturing strategy and rapid release testing, enables delivery ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...

While a Trump administration decision to recompete several Tech Hub awards prompted frustration among supporters of the ...